Welcome to our dedicated page for AvePoint SEC filings (Ticker: AVPT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
AvePoint, Inc. filings document the company’s financial results, governance matters, capital structure and public-company securities activity. Form 8-K reports furnish quarterly and annual operating results, including SaaS revenue, total revenue, annual recurring revenue and related financial-condition disclosures tied to the company’s cloud data protection business.
Proxy materials and annual meeting reports cover director elections, executive compensation votes, auditor ratification and board governance. Other filings address common stock offering activity under shelf registration materials, the company’s secondary listing context for common stock, and the removal of AvePoint warrants from Nasdaq listing and registration.
AvePoint, Inc. (AVPT) Form 4 summary: The company’s Chief Legal Officer and director, Brian Michael Brown, reported two transactions in September 2025. On 09/19/2025 he had 1,547 shares disposed at $15.67 each, identified as withholding of shares to satisfy tax obligations upon vesting. On 09/22/2025 he reported a 30,000-share acquisition tied to the exercise of stock options (exercise price $1.3357) with a reported price of $15.75. Following these transactions, the filing shows 668,741 shares of common stock directly held and an aggregate beneficial ownership of 2,286,102 shares (including derivative securities and RSUs).
Jiang Tianyi, who serves as Chief Executive Officer and a director of AvePoint, Inc. (AVPT), reported a transaction on 09/19/2025 in which 4,706 shares of common stock were disposed of at $15.67 per share. The filing states this disposition was an exempt, non-discretionary transaction consisting of shares withheld by the company to satisfy income tax withholding obligations related to the net settlement of vested restricted stock units (RSUs). After the withholding, the reporting person beneficially owned 551,634 shares, which includes both non-RSU common stock and vested and unvested RSUs previously reported. The transaction was signed by an attorney-in-fact on 09/23/2025.
AvePoint director and Executive Chairman Gong Xunkai reported a transaction on 09/19/2025 relating to the company’s common stock and restricted stock units under the 2021 Equity Incentive Plan. The filing shows 6,500 shares were disposed of at an effective price of $15.67 in an exempt transaction where shares were withheld to satisfy tax withholding obligations on RSU vesting. After the withholding, the reporting person beneficially owned 763,702 shares (including vested and unvested RSUs). The Form 4 was signed by an attorney-in-fact on 09/23/2025.
Caci James, AvePoint (AVPT) Chief Financial Officer, reported a withholding of 2,823 shares on 09/19/2025 at a price of $15.67 per share to satisfy tax obligations related to vested restricted stock units (RSUs). The filing states this was an exempt, non‑discretionary transaction consisting of delivery/withholding of shares to pay taxes in connection with RSU vesting. Following the transaction, the reporting person beneficially owns 210,207 shares, which includes vested and unvested RSUs held under previously reported grant schedules.
AvePoint, Inc. (AVPT) filing reports a proposed sale of 35,000 common shares through Rockefeller Financial with an aggregate market value of $543,633.74, with an approximate sale date of 09/23/2025. The shares were originally received as a restricted stock grant on 07/07/2022 and were granted as compensation. The issuer has 211,926,808 shares outstanding. The filer previously sold three blocks of 35,000 shares on 06/23/2025, 07/23/2025 and 08/25/2025, with gross proceeds shown for each transaction. The notice includes the standard representation regarding absence of undisclosed material information.
AvePoint director John Chi On Ho reported the sale of 650,000 shares of common stock on 09/18/2025 at $15.21 per share. The filing shows the shares were sold to provide initial liquidity for the company's secondary listing on the Singapore Exchange; no shares were sold on Nasdaq in connection with this transaction. After the sale, the reporting person is shown as beneficially owning 3,732,679 shares indirectly through Balmoral Blue Limited, subject to a disclaimer of full beneficial ownership.
The sale was executed under Rule 144 and the company's insider trading policies. The report is limited to this non-derivative equity transaction and explains the reporting person’s indirect ownership via Balmoral Blue Limited.
AvePoint Executive Chairman and Director Gong Xunkai reported a sale of 2,068,966 common shares on 09/18/2025 at $15.21 per share conducted in connection with AvePoint's secondary listing on the Singapore Exchange Securities Trading Limited (SGX-ST). The filing states the sale facilitated initial liquidity for the SGX-ST listing, was executed in accordance with Rule 144 and applicable insider trading policies, and that no shares were sold on NASDAQ. Following the transaction the reporting person beneficially owns 15,220,668 shares, comprised of shares held by affiliated LLCs and trusts for which he is trustee, with a disclaimer limiting admission of beneficial ownership.
AvePoint director and CEO Dr. Jiang Tianyi reported a sale of 2,068,966 common shares at $15.21 per share on 09/18/2025 to facilitate initial liquidity for the company's secondary listing on the Singapore Exchange (SGX-ST). The filing states the sale complied with Rule 144 and insider trading policies and that no shares were sold on NASDAQ. After the transaction Dr. Jiang is reported to beneficially own 13,841,853 shares indirectly through trusts and LLCs, with the filing listing specific affiliated entities and trusts that hold those shares.
Caci James, Chief Financial Officer and director of AvePoint, Inc. (AVPT), reported a sale of 216,000 shares of the issuer's common stock on 09/18/2025 at a price of $15.21 per share executed on the Singapore Exchange Securities Trading Limited (SGX-ST) to facilitate initial liquidity related to the company's SGX-ST secondary listing. The filing states the transaction complied with Rule 144 and the company's insider trading policies. Following the reported sale, the reporting person beneficially owns 213,030 shares, which include non-RSU common stock and both vested and unvested restricted stock units (RSUs) granted under the 2021 Equity Incentive Plan as previously disclosed.
AvePoint insider sale of 500,000 shares to support SGX secondary listing. Brian Michael Brown, who serves as Chief Legal Officer and a Director, sold 500,000 shares of AvePoint common stock on 09/18/2025 at $15.21 per share as part of the company’s secondary listing on the Singapore Exchange to facilitate initial liquidity. The filing states no shares were sold on NASDAQ and the transaction was executed in accordance with Rule 144 and company insider trading policies. After the sale the report shows 640,288 shares beneficially owned indirectly, held by the Brian M. Brown Revocable Trust.